Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Herron
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Chemicals & Drugs
Living Beings
Anatomy
Occupations
Sign-in to see full Profile
Network (preview)
9
Goodson, Theodore
7
Sawyer, Scott
6
Froelich, Larry
5
Smith, Gerald
5
Tinsley, Jennifer
5
Weir, Leonard
5
Wiley, Michael
5
Klimkowski, Valentine
5
Craft, Trelia
4
Beight, Douglas
4
Franciskovich, Jeffry
4
Fleisch, JH
4
Kyle, Jeffrey
4
Masters, John
4
Ratz, Andrew
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Herron (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2007: Mendel David; Marquart Angela L; Joseph Sajan; Waid Philip; Yee Ying K; Tebbe Anne Louise; Ratz Andrew M; Herron David K; Goodson Theodore; Masters John J; Franciskovich Jeffry B; Tinsley Jennifer M; Wiley Michael R; Weir Leonard C; Kyle Jeffrey A; Klimkowski Valentine J; Smith Gerald F; Towner Richard D; Froelich Larry L; Buben John; Craft Trelia J
Anthranilamide inhibitors of factor Xa.
Bioorganic & medicinal chemistry letters 2007;17(17):4832-6.
-
2005: Peng Sheng-Bin; Yan Lei; Xia Xiaoling; Watkins Scott A; Brooks Harold B; Beight Douglas; Herron David K; Jones Michael L; Lampe John W; McMillen William T; Mort Nicholas; Sawyer J Scott; Yingling Jonathan M
Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Biochemistry 2005;44(7):2293-304.
-
2004: Sawyer J Scott; Beight Douglas W; Britt Karen S; Anderson Bryan D; Campbell Robert M; Goodson Theodore; Herron David K; Li Hong-Yu; McMillen William T; Mort Nicholas; Parsons Stephen; Smith Edward C R; Wagner Jill R; Yan Lei; Zhang Faming; Yingling Jonathan M
Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.
Bioorganic & medicinal chemistry letters 2004;14(13):3581-4.
-
2003: Sawyer J Scott; Anderson Bryan D; Beight Douglas W; Campbell Robert M; Jones Michael L; Herron David K; Lampe John W; McCowan Jefferson R; McMillen William T; Mort Nicholas; Parsons Stephen; Smith Edward C R; Vieth Michal; Weir Leonard C; Yan Lei; Zhang Faming; Yingling Jonathan M
Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.
Journal of medicinal chemistry 2003;46(19):3953-6.
-
2000: Masters J J; Franciskovich J B; Tinsley J M; Campbell C; Campbell J B; Craft T J; Froelich L L; Gifford-Moore D S; Hay L A; Herron D K; Klimkowski V J; Kurz K D; Metz J T; Ratz A M; Shuman R T; Smith G F; Smith T; Towner R D; Wiley M R; Wilson A; Yee Y K
Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity.
Journal of medicinal chemistry 2000;43(11):2087-92.
-
2000: Wiley M R; Weir L C; Briggs S; Bryan N A; Buben J; Campbell C; Chirgadze N Y; Conrad R C; Craft T J; Ficorilli J V; Franciskovich J B; Froelich L L; Gifford-Moore D S; Goodson T; Herron D K; Klimkowski V J; Kurz K D; Kyle J A; Masters J J; Ratz A M; Milot G; Shuman R T; Smith T; Smith G F; Tebbe A L; Tinsley J M
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.
Journal of medicinal chemistry 2000;43(5):883-99.
-
2000: Yee Y K; Tebbe A L; Linebarger J H; Beight D W; Craft T J; Gifford-Moore D; Goodson T; Herron D K; Klimkowski V J; Kyle J A; Sawyer J S; Smith G F; Tinsley J M; Towner R D; Weir L; Wiley M R
N(2)-Aroylanthranilamide inhibitors of human factor Xa.
Journal of medicinal chemistry 2000;43(5):873-82.
-
2000: Herron D K; Goodson T; Wiley M R; Weir L C; Kyle J A; Yee Y K; Tebbe A L; Tinsley J M; Mendel D; Masters J J; Franciskovich J B; Sawyer J S; Beight D W; Ratz A M; Milot G; Hall S E; Klimkowski V J; Wikel J H; Eastwood B J; Towner R D; Gifford-Moore D S; Craft T J; Smith G F
1,2-Dibenzamidobenzene inhibitors of human factor Xa.
Journal of medicinal chemistry 2000;43(5):859-72.
-
1999: Jackson W T; Froelich L L; Boyd R J; Schrementi J P; Saussy D L; Schultz R M; Sawyer J S; Sofia M J; Herron D K; Goodson T; Snyder D W; Pechous P A; Spaethe S M; Roman C R; Fleisch J H
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
The Journal of pharmacology and experimental therapeutics 1999;288(1):286-94.
-
1998: Bridonneau P; Chang Y F; O'Connell D; Gill S C; Snyder D W; Johnson L; Goodson T; Herron D K; Parma D H
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
Journal of medicinal chemistry 1998;41(6):778-86.
-
1996: Eacho P I; Foxworthy P S; Lawrence J W; Herron D K; Noonan D J
Common structural requirements for peroxisome proliferation by tetrazole and carboxylic acid-containing compounds.
Annals of the New York Academy of Sciences 1996;804():387-402.
-
1995: Herron D K; Bollinger N G; Chaney M O; Varshavsky A D; Yost J B; Sherman W R; Thingvold J A
Visualization and comparison of molecular dynamics simulations of leukotriene C4, leukotriene D4, and leukotriene E4.
Journal of molecular graphics 1995;13(6):337-41.
-
1994: Harper R W; Jackson W T; Froelich L L; Boyd R J; Aldridge T E; Herron D K
Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
Journal of medicinal chemistry 1994;37(15):2411-20.
-
1992: Silbaugh S A; Stengel P W; Cockerham S L; Roman C R; Saussy D L; Spaethe S M; Goodson T; Herron D K; Fleisch J H
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.
European journal of pharmacology 1992;223(1):57-64.
-
1992: Marder P; Schultz R M; Spaethe S M; Sofia M J; Herron D K
Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils.
Prostaglandins, leukotrienes, and essential fatty acids 1992;46(4):265-70.
-
1992: Herron D K; Goodson T; Bollinger N G; Swanson-Bean D; Wright I G; Staten G S; Thompson A R; Froelich L L; Jackson W T
Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
Journal of medicinal chemistry 1992;35(10):1818-28.
-
1992: Harper R W; Herron D K; Bollinger N G; Sawyer J S; Baldwin R F; Roman C R; Rinkema L E; Fleisch J H
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists.
Journal of medicinal chemistry 1992;35(7):1191-200.
-
1991: Hermann R B; Herron D K
OVID and SUPER: two overlap programs for drug design.
Journal of computer-aided molecular design 1991;5(6):511-24.
-
1991: Wetmore L A; Gerard N P; Herron D K; Bollinger N G; Baker S R; Feldman H A; Drazen J M
Leukotriene receptor on U-937 cells: discriminatory responses to leukotrienes C4 and D4.
The American journal of physiology 1991;261(2 Pt 1):L164-71.
-
1991: Schultz R M; Marder P; Spaethe S M; Herron D K; Sofia M J
Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production.
Prostaglandins, leukotrienes, and essential fatty acids 1991;43(4):267-71.
-
1989: Eacho P I; Foxworthy P S; Dillard R D; Whitesitt C A; Herron D K; Marshall W S
Induction of peroxisomal beta-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: structure-activity relationships.
Toxicology and applied pharmacology 1989;100(1):177-84.
-
1988: Herron D K; Whitesitt C A; Mallet B E; Rinkema L E; Haisch K D; Fleisch J H
Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
Drugs under experimental and clinical research 1988;14(5):303-10.
-
1987: Silbaugh S A; Stengel P W; Williams G D; Herron D K; Gallagher P; Baker S R
Effects of leukotriene B4 inhalation. Airway sensitization and lung granulocyte infiltration in the guinea pig.
The American review of respiratory disease 1987;136(4):930-4.
Sign-in to see more
